Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Thromb Res. 2018 Mar 7;165:1–5. doi: 10.1016/j.thromres.2018.03.001

Table 2. MV TF activity in non-cancer severely ill patients.

Indication for hospitalization MV TF activity (pg/mL), median [IQR] vs healthy controls
Infection (n=7) 0.28 [0.13-0.96] P=0.0082
Liver failure (n=5) 0.28 [0.12-0.35] NS
VTE (n=4) 0.20 [0.03-0.46] NS
Ischemic stroke (n=14) 0.08 [0-0.15] NS
Major fracture (n=3) 0.31 [0-0.09] NS
Confusion (n=6) 0.07 [0.05-0.07] NS
Hyperglycemia (n=2) 0.32 [0.08-0.56] -
COPD (n=2) 0.19 [0-0.38] -
Acute anemia (n=2) 0.09 [0.07-0.11] -
Intoxication (n=1) 0.36 -
Inflammatory bowel disease (n=1) 0.25 -
MI (n=1) 0.12 -
Renal failure (n=1) 0.12 -
Hyponatremia (n=1) 0 -
Epileptic seizure (n=1) 0 -